Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 20;8(3):295-311.
doi: 10.1007/s13167-017-0101-y. eCollection 2017 Sep.

Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Affiliations
Review

Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Maria Vadalà et al. EPMA J. .

Abstract

Autoimmune diseases, including multiple sclerosis and type 1 diabetes mellitus, affect about 5% of the worldwide population. In the last decade, reports have accumulated on various autoimmune disorders, such as idiopathic thrombocytopenia purpura, myopericarditis, primary ovarian failure, and systemic lupus erythematosus (SLE), following vaccination. In this review, we discuss the possible underlying mechanisms of autoimmune reactions following vaccinations and review cases of autoimmune diseases that have been correlated with vaccination. Molecular mimicry and bystander activation are reported as possible mechanisms by which vaccines can cause autoimmune reactions. The individuals who might be susceptible to develop these reactions could be especially not only those with previous post-vaccination phenomena and those with allergies but also in individuals who are prone to develop autoimmune diseases, such as those with a family history of autoimmunity or with known autoantibodies, and the genetic predisposed individuals. Further research is encouraged into the direct associations between vaccines and autoimmune conditions, and the biological mechanisms behind them.

Keywords: Diabetes; Genetic test; Individualized patient profile; Multiple sclerosis; Predictive preventive personalized medicine; Vaccine.

PubMed Disclaimer

Conflict of interest statement

Funding

This study is not funded.

Conflict of interest

The authors declare that they have no conflict of interest.

References

    1. Nabel GJ. Designing tomorrow’s vaccines. N Engl J Med. 2013;368(6):551–560. doi: 10.1056/NEJMra1204186. - DOI - PMC - PubMed
    1. Ansakorpi H, et al. Lambert-Eaton myasthenic syndrome following H1N1-influenza vaccination: a case report. Acta Neurol Scand. 2012;126(5):e25–e28. doi: 10.1111/j.1600-0404.2012.01675.x. - DOI - PubMed
    1. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994) Pediatr Infect Dis J. 1996;15(1):88–90. doi: 10.1097/00006454-199601000-00020. - DOI - PubMed
    1. Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol. 2000;18(2):181–184. - PubMed
    1. Stratton KR, Howe CJ, Johnston RB., Jr Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA. 1994;271(20):1602–1605. doi: 10.1001/jama.1994.03510440062034. - DOI - PubMed

LinkOut - more resources